▲ Peaking
Business
Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
Merck beats quarterly estimates and raises its profit outlook, driven by growth in Keytruda and Winrevair.
Winrevair
1 trends tracked about this subject — the full history, oldest to newest below.